Insider Trading activities at Metagenomi, Inc. (MGX)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Metagenomi, Inc. (MGX) since 2024 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Metagenomi, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1785279.

Total stock buying since 2024: $13,025,000.
Total stock sales since 2024: $68,404.
Total stock option exercises since 2024: $0.


6 insiders reported insider trading activities at Metagenomi, Inc. (MGX):
Insider trading activities of Wapnick Pamela
Insider trading activities of Wein Matthew
Insider trading activities of Thomas Brian C.
Insider trading activities of Noonberg Sarah B.
Insider trading activities of Irish Jian
Insider trading activities of Novo Holdings A/s

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Metagenomi, Inc. (MGX).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2025 0 $0 26,927 $47,462 0 $0
2024 900,000 $13,025,000 7,824 $20,942 0 $0

Table 2. Monthly summary of insider trading at Metagenomi, Inc. (MGX).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2025-06 0 $0 24,189 $42,329 0 $0
2025-03 0 $0 2,738 $5,133 0 $0
2024-12 0 $0 1,559 $2,899 0 $0
2024-09 0 $0 6,265 $18,043 0 $0
2024-02 900,000 $13,025,000 0 $0 0 $0

Table 3. Detailed insider trading at Metagenomi, Inc. (MGX)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2025-06-06 Wein Matthew (See Remarks) Sale 199 1.75 348
2025-06-06 Thomas Brian C. (Chief Executive Officer) Sale 10,785 1.75 18,873
2025-06-06 Irish Jian (See Remarks) Sale 6,390 1.75 11,182
2025-06-06 Wapnick Pamela (Chief Financial Officer) Sale 1,576 1.75 2,758
2025-06-06 Noonberg Sarah B. (Chief Medical Officer) Sale 5,239 1.75 9,168
2025-03-05 Wein Matthew (See Remarks) Sale 930 1.88 1,743
2025-03-05 Wapnick Pamela (Chief Financial Officer) Sale 1,808 1.88 3,390
2024-12-05 Wapnick Pamela (Chief Financial Officer) Sale 1,559 1.86 2,899
2024-09-05 Wapnick Pamela (Chief Financial Officer) Sale 6,265 2.88 18,043
2024-02-13 Novo Holdings A/s (10% Owner) Buy 800,000 15.00 12,000,000
2024-02-09 Novo Holdings A/s (10% Owner) Buy 100,000 10.25 1,025,000

Insider trading activities including stock purchases, stock sales, and option exercises of MGX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Metagenomi, Inc. (symbol MGX, CIK number 1785279) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.